Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failure undergoing endomyocardial biopsy.

Mueller KA, Tavlaki E, Schneider M, Jorbenadze R, Geisler T, Kandolf R, Gawaz M, Mueller II, Zuern CS.

J Card Fail. 2013 Oct;19(10):678-84. doi: 10.1016/j.cardfail.2013.09.001.

PMID:
24125106
2.

Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy.

Zuern CS, Müller KA, Seizer P, Geisler T, Banya W, Klingel K, Kandolf R, Bauer A, Gawaz M, May AE.

Eur J Heart Fail. 2013 Feb;15(2):176-84. doi: 10.1093/eurjhf/hfs185.

3.

[The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].

Zhao XY, Yang YJ, Zhang J, Dang AM, Ni XH, Huang J, Kang S, Ma WH, Zhao DY.

Zhonghua Yi Xue Za Zhi. 2006 May 9;86(17):1165-9. Chinese.

PMID:
16796855
4.

Prognostic value of indeterminable anaerobic threshold in heart failure.

Agostoni P, Corrà U, Cattadori G, Veglia F, Battaia E, La Gioia R, Scardovi AB, Emdin M, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Cicoira M, Salvioni E, Giovannardi M, Mezzani A, Scrutinio D, Di Lenarda A, Mantegazza V, Ricci R, Apostolo A, Iorio A, Paolillo S, Palermo P, Contini M, Vassanelli C, Passino C, Piepoli MF; MECKI Score Research Group..

Circ Heart Fail. 2013 Sep 1;6(5):977-87. doi: 10.1161/CIRCHEARTFAILURE.113.000471.

5.

Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study.

Perna ER, Aspromonte N, Cimbaro Canella JP, Di Tano G, Macin SM, Feola M, Coronel ML, Milani L, Parras JI, Milli M, García EH, Valle R.

J Card Fail. 2012 Nov;18(11):822-30. doi: 10.1016/j.cardfail.2012.10.008.

PMID:
23141854
6.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80.

7.

Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis.

Milano AD, Faggian G, Dodonov M, Golia G, Tomezzoli A, Bortolotti U, Mazzucco A.

J Thorac Cardiovasc Surg. 2012 Oct;144(4):830-7. doi: 10.1016/j.jtcvs.2011.11.024.

8.

Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.

Zuern CS, Walker B, Sauter M, Schaub M, Chatterjee M, Mueller K, Rath D, Vogel S, Tegtmeyer R, Seizer P, Geisler T, Kandolf R, Lang F, Klingel K, Gawaz M, Borst O.

Clin Res Cardiol. 2015 Dec;104(12):1033-43. doi: 10.1007/s00392-015-0871-y.

PMID:
26008895
9.

Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure. -Comparison between preserved and reduced ejection fraction heart failure.-.

Aoki T, Fukumoto Y, Sugimura K, Oikawa M, Satoh K, Nakano M, Nakayama M, Shimokawa H.

Circ J. 2011;75(11):2605-13.

11.

Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.

Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F; ALPHA Study Group Investigators..

J Am Coll Cardiol. 2007 Nov 6;50(19):1896-904.

12.

Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults.

Parson SJ, Russell SD, Bennett MK, Dunn JM, Gilotra NA, Rao S, Harrington C, Freitag TB, Foster MC, Halushka MK.

Cardiovasc Pathol. 2012 Jul-Aug;21(4):317-23. doi: 10.1016/j.carpath.2011.11.002.

PMID:
22153555
13.

Predictors of outcome in patients with suspected myocarditis.

Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, Lindinger A, Böhm M.

Circulation. 2008 Aug 5;118(6):639-48. doi: 10.1161/CIRCULATIONAHA.108.769489. Erratum in: Circulation.2008 Sep 16;118(12): e493.

14.

Cardiac troponin T vs other biochemical markers in patients with congestive heart failure.

Nishio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, Morimoto T, Kimura T, Kita T.

Circ J. 2007 May;71(5):631-5.

15.

CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failure.

Borst O, Schaub M, Walker B, Sauter M, Muenzer P, Gramlich M, Mueller K, Geisler T, Lang F, Klingel K, Kandolf R, Bigalke B, Gawaz M, Zuern CS.

Int J Cardiol. 2014 Oct 20;176(3):896-903. doi: 10.1016/j.ijcard.2014.08.033.

PMID:
25223819
16.

Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides.

Kusumoto A, Miyata M, Kubozono T, Ikeda Y, Shinsato T, Kuwahata S, Fujita S, Takasaki K, Yuasa T, Hamasaki S, Tei C.

J Cardiol. 2012 Mar;59(2):202-8. doi: 10.1016/j.jjcc.2011.11.012.

17.

[Circulating adhesion molecules (cICAM-1, lcVCAM-1) in patients with suspected inflammatory heart muscle disease].

Klein RM, Breuer R, Mundhenke M, Schwartzkopff B, Strauer BE.

Z Kardiol. 1998 Feb;87(2):84-93. German.

PMID:
9556870
18.

Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.

Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T, Ohba K, Matsubara J, Maeda H, Horibata Y, Sakamoto K, Sugamura K, Yamamuro M, Sumida H, Kaikita K, Iwashita S, Matsui K, Kimura K, Umemura S, Ogawa H.

J Am Coll Cardiol. 2012 Oct 30;60(18):1778-86. doi: 10.1016/j.jacc.2012.07.036.

19.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group..

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027.

20.

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L.

Circ Heart Fail. 2011 Mar;4(2):145-52. doi: 10.1161/CIRCHEARTFAILURE.110.957332.

Supplemental Content

Support Center